In a surprising turn of events, the Food and Drug Administration (FDA) has agreed to delete its widely discussed “You are not a horse” social media post, among others, as part of a settlement in an ongoing ivermectin case. This development marks a significant pivot in the agency’s communication strategy regarding the use of ivermectin, an antiparasitic drug that gained controversial fame during the pandemic.

Ivermectin, traditionally used to treat parasitic worms in both humans and animals, became a topic of intense debate during the COVID-19 pandemic. Some groups promoted it as a potential treatment for the virus, despite a lack of comprehensive clinical trials to support its efficacy and safety for this purpose. In response, the FDA launched a campaign to discourage its use for treating COVID-19, culminating in a now-famous tweet cautioning against self-medication with ivermectin, especially formulations intended for livestock. The tweet, humorously warning “You are not a horse,” quickly went viral, becoming a symbol of the FDA’s efforts to combat misinformation regarding COVID-19 treatments.

The decision to delete the tweet and other related content comes as the FDA settles a lawsuit brought by a group advocating for ivermectin’s use against COVID-19. The plaintiffs argued that the FDA’s statements overstepped its regulatory authority by effectively prescribing or advising against specific treatments, a role traditionally reserved for practicing physicians. They contended that the FDA’s communications had a chilling effect on the willingness of healthcare providers to consider or prescribe ivermectin for COVID-19, despite the drug’s approval for human use in other contexts.

This settlement raises important questions about the balance between regulatory agencies’ roles in safeguarding public health and the limits of their authority in influencing medical practice and public opinion. By agreeing to remove the contentious posts, the FDA may be signaling a more cautious approach to its public health communications, especially concerning treatments for emerging health threats like COVID-19.

The deletion of the “You are not a horse” post and others does not imply an endorsement of ivermectin as a COVID-19 treatment by the FDA. The agency maintains its stance that more research is needed to conclusively determine ivermectin’s efficacy and safety for treating COVID-19 in humans. However, this development underscores the complex interplay between science, public health policy, and freedom of speech in the digital age.

As the scientific community continues to explore treatments for COVID-19 and other emerging health challenges, the lessons learned from the ivermectin controversy will likely influence how regulatory agencies communicate with the public. In an era where misinformation can spread as rapidly as any virus, the need for clear, accurate, and respectful public health messaging has never been more critical.